Senior Medical Director
ViiV Healthcare
Disclosure: ViiV Healthcare (Employee)
M. Keith Rawlings, MD is Senior Medical Director at ViiV Healthcare. He has over 30 years of HIV clinical, research and administrative experience. Prior to ViiV Healthcare, Dr. Rawlings was Director, HIV Medical Sciences at Gilead Sciences, where he oversaw education and training on HIV prevention, along with the regulatory submission, approval and implementation of Truvada for pre-exposure prophylaxis in the US.
Dr. Rawlings was Medical Director, Director of Clinical Research and the AIDS Clinical Trials Group (ACTG) Site Leader and Principal Investigator for the AIDS Arms, Inc in Dallas, TX. Dr. Rawlings has previously served: as Chair of Internal Medicine Section and Co-Chair of the Infectious Diseases/ HIV program of the National Medical Association (NMA); on the Health Resources and Services Administration (HRSA) AIDS Advisory Committee; as Co-Principal Investigator and Advisory Board member of the National Minority AIDS Education & Training Center; as a member of the Board of Directors of the American Academy of HIV Medicine; and on the South African Presidential HIV Advisory Board. He has published over 100 articles, abstracts and manuscripts and co-edited one of the few books, HIV/AIDS in U.S. Communities of Color, which addressed the HIV epidemic among minorities in the US.
